Furthermore, the elevated expression of DENND2D was associated with the enhanced infiltration of immune cells, suggesting that DENND2D contributes to prostate cancer suppression through its combined effects on oncogenic pathways and immune modulation. Here, DENND2D is linked to prostate carcinoma.